Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

Time to Relapse After 6 and 12 Months' Treatment of Generalized Anxiety Disorder With Venlafaxine Extended Release

(2010) Karl Rickels et al.   ARCHIVES OF GENERAL PSYCHIATRY

HTR2A gene variation is involved in antidepressant treatment response

(2009) Susanne Lucae et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Refractory Generalized Anxiety Disorder

(2009) Mark H. Pollack   JOURNAL OF CLINICAL PSYCHIATRY

Pharmacogenetics of anxiolytic drugs

(2009) Arun K. Tiwari et al.   JOURNAL OF NEURAL TRANSMISSION

Polymorphisms in GRIK4, HTR2A and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

(2009) Sonja Horstmann et al.   NEUROPSYCHOPHARMACOLOGY

Genetic predictors of response to antidepressants in the GENDEP project

(2009) Rudolf Uher et al.   PHARMACOGENOMICS JOURNAL

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

(2008) M Kato et al.   MOLECULAR PSYCHIATRY

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

(2008) Eric J. Peters et al.   Pharmacogenetics and Genomics

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

(2008) V.J. Aloyo et al.   PHARMACOLOGY & THERAPEUTICS